These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24176558)

  • 1. Waiting for prevention in Australia.
    Antill Y
    Lancet Oncol; 2013 Nov; 14(12):1157-8. PubMed ID: 24176558
    [No Abstract]   [Full Text] [Related]  

  • 2. The science of precision prevention of cancer.
    Vineis P; Wild CP
    Lancet Oncol; 2017 Aug; 18(8):997-998. PubMed ID: 28759370
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis.
    Martin-Moreno JM; Anttila A; von Karsa L; Alfonso-Sanchez JL; Gorgojo L
    Eur J Cancer; 2012 Sep; 48(14):2212-8. PubMed ID: 22424881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHA passes resolution on cancer prevention and control.
    Burki TK
    Lancet Oncol; 2017 Jul; 18(7):858. PubMed ID: 28602774
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.
    Lertkhachonsuk AA; Yip CH; Khuhaprema T; Chen DS; Plummer M; Jee SH; Toi M; Wilailak S;
    Lancet Oncol; 2013 Nov; 14(12):e497-507. PubMed ID: 24176569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of improved cancer survival rates: better outcomes, higher costs.
    Uyl-de Groot CA; de Groot S; Steenhoek A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):283-92. PubMed ID: 20545593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer epigenetics as biomarkers of clinical significance.
    Panayiotidis MI
    Cancer Lett; 2014 Jan; 342(2):168-9. PubMed ID: 24183850
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer in Mexico: a growing challenge to health and the health system.
    Chávarri-Guerra Y; Villarreal-Garza C; Liedke PE; Knaul F; Mohar A; Finkelstein DM; Goss PE
    Lancet Oncol; 2012 Aug; 13(8):e335-43. PubMed ID: 22846838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-consumer genetic tests: flawed and unethical.
    Lancet Oncol; 2008 Dec; 9(12):1113. PubMed ID: 19038754
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the costs of cancer treatment – what model should we use?
    Weller D
    Eur J Cancer Care (Engl); 2015 May; 24(3):283-5. PubMed ID: 25876018
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease prevention and implications for worksite health promotion programs in Brazil.
    Cipriano G; Neves LM; Cipriano GF; Chiappa GR; Borghi-Silva A
    Prog Cardiovasc Dis; 2014; 56(5):493-500. PubMed ID: 24607013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is high and growing spending on cancer treatment and prevention harmful to the United States economy?
    Pauly MV
    J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935
    [No Abstract]   [Full Text] [Related]  

  • 13. Risks of online direct-to-consumer tumor markers for cancer screening.
    Lovett KM; Liang BA; Mackey TK
    J Clin Oncol; 2012 May; 30(13):1411-4. PubMed ID: 22355060
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer control in Australia. A public health perspective.
    Kober T
    Aust Fam Physician; 1997 Sep; 26(9):1009, 1011. PubMed ID: 9382712
    [No Abstract]   [Full Text] [Related]  

  • 15. Closing the gap in clinical preventive services.
    Teutsch SM; Fielding JE
    Am J Prev Med; 2010 Jun; 38(6):684-5. PubMed ID: 20494249
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention may be more expensive than cure.
    Butler JA
    J R Soc Med; 1993 Jun; 86(6):341-4. PubMed ID: 8315628
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer risk assessment and cancer prevention: promises and challenges.
    Reid BJ
    Cancer Prev Res (Phila); 2008 Sep; 1(4):229-32. PubMed ID: 19138965
    [No Abstract]   [Full Text] [Related]  

  • 18. Safe harbor.
    Kiser K
    Minn Med; 2009 Feb; 92(2):6-7, 9. PubMed ID: 19331281
    [No Abstract]   [Full Text] [Related]  

  • 19. A role for payers: remarks on the use of data and analytics in support of preventive care.
    Tuckson RV
    Am J Prev Med; 2013 Jan; 44(1 Suppl 1):S27-9. PubMed ID: 23195162
    [No Abstract]   [Full Text] [Related]  

  • 20. A prescription for Ontario's Wait Time Strategy.
    Collins-Nakai R; Adams O; Saulnier M
    Healthc Pap; 2006; 7(1):46-50; discussion 74-7. PubMed ID: 16914940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.